AO
Schedule 13G filing
ADVANCE ON VENTURES Ltd disclosed a 7.5% stake in Advanced Biomed Inc. (ADVB)
ADVANCE ON VENTURES Ltd reported owning 7.5% of Advanced Biomed Inc. (ADVB) (123,840 shares) in a Schedule 13G filed Sep 22, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.